FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> Medicare Part D | Medicare | drug costs

Part D premiums rise 24 percent

Tools

The pharma friend that is Medicare Part D will be more expensive for seniors next year. On average, premiums for the 10 most popular drug-coverage plans will leap by 31 percent. And for all standalone drug plans, the average price hike amounts to 24 percent, to $37 monthly. Meanwhile, Center for Medicare Services chief Kerry Weems is warning that plans may have made "significant" changes in coverage, and he urges seniors to carefully scrutinize their drug plans.

One area that Weems pointed out was drug coverage during the "gap"--the so-called donut hole where benefits drop off once seniors have spent $2,510 on meds. Beneficiaries can buy extra coverage to span the gap, but at an additional cost, of course.

Health plans are blaming their own inaccurate forecasting for increased premiums and coverage cuts. "If [premium] prices are increasing more on the midlevel plans, it's simply because our experience tells us that's where we need to be--premium-wise--to cover our actual costs plus a small margin," a Humana spokesman said. And UnitedHealth Group blamed high Medicare drug costs for its poor earnings this year.

- see the story at WebMD
- read the Wall Street Journal's article

Related Articles:
Part D 'windfall' for pharma, report says
Medicare overpays for new generics
Obama, McCain united against drug costs
Medicare program helps slow rate of drug spending (Feb 2007)

More stories about Medicare Part D   Medicare   drug costs  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 7 + 11?
To combat spam, please solve the math question above.